标普和纳斯达克内在价值 联系我们

Huaizhong Health Group, Inc. ADAD OTC

Other OTC • Financial Services • Shell Companies • CN • USD

SharesGrow Score
17/100
0/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Huaizhong Health Group, Inc. (ADAD) .

本页证实的标准:

  • VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。

SharesGrow 综合评分: 16/100 其中 0/7 项标准通过。

SharesGrow 7-Criteria Score
17/100
SG Score
View full scorecard →
价值
N/A
No coverage
未來
N/A
No coverage
过去
0/100
→ Income
健康
0/100
Debt-to-Equity & liquidity
→ Health
护城河
11/100
→ Income
~
成长
58/100
→ Income
收入
N/A
No coverage

估值概览 — ADAD

估值倍数
P/E (TTM)0.0
前瞻 P/EN/A
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率0.00
EV/EBITDA0.0
每股数据
EPS (TTM)$0.00
每股账面价值$0.00
每股营收$0.00
每股自由现金流$0.00
收益率与内在价值
盈利收益率N/A
股息收益率0.00%

EPS:实际 vs 预期

P/E Ratio & Earnings Yield

每股收益 (EPS) 历史

Year EPS(稀释) 营收 净利润 净利润率
2013 $0.00 $0.00 $-72.00 -
2014 $90.89 $91.31K $22.72K 24.9%
2015 $-153.15 $105.84K $-47.78K -45.1%
2016 $2.46 $41.63K $866.00 2.1%
2017 $-0.60 $40.51K $-78.13K -192.9%
2018 $-0.02 $20.55K $-6.37K -31%
2019 $-0.41 $20.55K $-126K -613%
2020 $0.00 $0.00 $-36.48K -
2021 $0.00 $0.00 $-30.83K -
2022 $0.00 $0.00 $-29.17K -
联系我们
🎓
SharesGrow 学院
学习如何计算内在价值,发现被低估的股票。
每周在线课程
给我们留言